Lunit Partners with Samsung Electronics to Launch AI Solution Sales

Medical AI company Lunit announced on the 16th that it has signed a supply contract with Samsung Electronics for two AI solution products. The contract amount is $1.86 million (approximately 2.5 billion KRW) over three years, which corresponds to 17.7% of the 2022 sales revenue.

Lunit's chest X-ray AI image analysis solution 'Lunit INSIGHT CXR'
[Photo by Lunit]

Through this contract, Lunit will supply Samsung Electronics with the chest X-ray AI image analysis solution 'Lunit Insight CXR' and the emergency disease AI automatic classification solution 'Lunit Insight CXR Triage.' Samsung Electronics plans to install Lunit's AI solutions in premium mobile and fixed X-ray imaging devices and sell them overseas.

Lunit Insight CXR is an AI solution that assists medical professionals by detecting 10 types of chest diseases such as lung nodules, fibrosis, and calcification from chest X-ray images. Lunit Insight CXR Triage is an AI solution that automatically classifies normal and abnormal findings of emergency diseases such as pneumothorax and pleural effusion. It received approval from the U.S. Food and Drug Administration (FDA) in 2021.

The two companies will focus on selling X-ray imaging devices equipped with AI solutions in North American markets such as the United States and Canada, as well as in Europe. They plan to expand their sales network to the Middle East, South America, and Southeast Asia in the future. Given that Lunit Insight CXR Triage excels at quickly and accurately classifying imaging information requiring emergency care, they intend to concentrate their sales efforts on hospital intensive care units and emergency rooms.

Seobum Seok, CEO of Lunit, said, "Lunit has formed partnerships with leading global medical device companies such as GE Healthcare, Philips, and Fujifilm and is working to expand the market, currently supplying AI solutions to more than 3,000 medical institutions worldwide. This partnership with Samsung Electronics, which has competitiveness through the development of premium X-ray imaging devices, will be a special opportunity to elevate the global market share of both companies to a higher level."

This content was produced with the assistance of AI translation services.